In vivo antiplasmodial, analgesic and anti-inflammatory activities of the leaf extract of Lippia multiflora mold

Journal of Medicinal Plants Research

Volumn 3, Issue 3, 2009, Pages 148-154

  Jigam, Ali A ^a   Akanya, Helmina O ^a   Ogbadoyi, Emmanuel O ^a   Dauda, Bukar E N ^a   Evans, Egwim C ^a  

^a FEDERAL UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Analgesia; Anti inflammatory; Bioactivity; Phytochemicals; Plasmodium berghei; Prophylaxis

Indexed keywords

ALKALOID DERIVATIVE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ESSENTIAL OIL; FLAVONOID; LIPPIA MULTIFLORA EXTRACT; SAPONIN DERIVATIVE; SPASMOLYTIC AGENT; TANNIN DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG PURIFICATION; DRUG SAFETY; DRUG SCREENING; FEMALE; IN VIVO STUDY; LIPPIA; LIPPIA MULTIFLORA; MALE; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; PLASMODIUM BERGHEI; RAT;

LIPPIA MULTIFLORA; MUS; PLASMODIUM BERGHEI; RATTUS;

EID: 73549096221     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Abena AA, Ngondzo - Kombeti GR, Bioka D (1998). Psychopharmacologic properties of Lippia multiflora. Encephale 24: 449-454.
2. Acquaye D, Smith M, Letchamo W, Simon J (2001). Lippia tea Centre for New Use Agriculture and Natural Products. Rutgers University, New Brunswick, New Jersey, USA.
3. Bloland PB (2001). Drug resistance in Malaria. Background Document for WHO Global Strategy for Containment of Antimicrobial Resistance. WHO, Switzerland pp. 3-27
4. Carter JA, Ross AJ, Neville BG, Obiero E, Katana K, Mung'ala - Odera V, Lees JANewton CR (2005). Developmental impairments following severe falciparum malaria in children. Tro.l Med. Int. Health 10:3-10.
5. CCAC (1997). Canadian Council on Animal Care Guidelines and Protocol Review
6. Cox F (2002). History of human parasitology. Clin. Microb. Rev. 15(4): 595 - 612.
7. Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S (2004). Antimalarial drug discovery: efficacy models for compound screening. Supplementary documents. Trends Parasitol pp.18-19.
8. Fletcher E (2007). Traditional remedies-Searching their natural sources for the next malaria drug. TDR news 79: 8-13.
9. Francois G, Bringmann G, Philpson JD, Ake-Assi Dochex C Rubenacker M (1994). Activity of extracts and naphythyl isoquinoline alkaloids from A.peltatum, A. abbreviatus and A. barteri against P. falciparum in vitro. Phytochem 35: 1461-1464.
10. Giles C (2005). Why don't we have a malaria vaccine? Welcome Science 1:12-13 Greenwood BM, Bojang K, Whitty CJ, Targett GA (2005). Malaria. Lancet 365: 1487-1498.
11. Haidet A (2003). The medicinal value of the rainforest. Final paper on tropical field courses submitted to the department of Interdisciplinary studies. Miami University, U. S. A.
12. Hay S, Guerra C, Tatetew A, Noor A, Slow R (2004). The global distribution and population at risk of malaria: past, present and future. Lancet of Infect. Dis. 4(6): 327-336,
13. Jigam AA, Akanya HO, Adeyemi JJ (2004). Antimicrobial and anti-plasmodial effects of Momordica balsamina. Nig. J. Nat. Prdt. Med. 8:11-12
14. Koster R, Anderson M, Debeer EJ (1959). Acetic acid method of analgesic screening. Curr. Opin. Immunol. 18:412
15. st edition Natural History Museum, London. pp. 136-145
16. Matuscheski K (2006). Vaccine development against malaria. Curr. Opin. Immunol 18(4): 449 - 457.
17. Munir AA (1993). A Taxonomic revision of the genus Lippia (Verbanacea) in Australia.J. Adelaide Bot. Garden 15: 129 - 145
18. Noedl H, Wongsrichanalai C, Wernsdorfer WH (2003). Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol. 19, 175-81
19. Odebiyi OO, Sofowora EA (1978). Phytochemical Screening of Nigerian Medicinal Plants II. Lloydia; 41: 234-235
20. th December, 2000. NICON HILTON HOTEL, Abuja Nigeria.
21. Oladimeji FA, Orafidiya OO, Oguniyi TA, Adewumi TA (2000). Pediculocidal and scabicidal properties of Lippia multiflora essential oil. J. Ethnopharmacol 72: 305-311
22. Pascual ME, Slowing K, Caretero E, Mara KD, Villar A (2001). Lippia: Traditional uses, chemistry and pharmacology: A Review J. Ethnopharmacol 76: 201-214
23. Pham HC, Koffi Y, Pham HA (1988a). Comparative hypotensive effects of compounds extracted from Lippia multiflora leaves. Planta Medica 54: 294-296
24. Pham HC, Koffi Y, Pham HA (1988b). Comparative hypotensive effects on TXA2 biosynthesis of products extracted from Lippia multi flora Mold leaves. Prostagladins, Leukotrienes and Essential Fatty Acids 34: 83-88
25. Sofowora A (1982). Medicinal plants and traditional medicine in Africa. John Wiley and sons Ltd USA. pp 142-145
26. Sofowora A (1986). The state of medicinal plants research in Nigeria. Nig. Soc. Pharmacog 25: 13-65
27. Taoubi K, Fauvel MT, Gleye J, Moulis C, Fouraste L (1997). Phenylpropanoid glycosides from Lantana camara and Lippia multiflora. Planta Medica 63: 192-193.
28. Terblanché FC, Kornelious G (1996). Essential oil constituents of the genus Lippia (Verbanaceae) - A Literature review. J. Essential Oil Res. 8: 471-485
29. Trease GE, Evans WC (1989). Pharmacology. Bailliare Tindal London. pp 378-480
30. Valentin A, Pelissier Y, Benoit F, Marion C, Kone D, Mallie M, Bastide JM, Bessieres JM (1995). Composition and anti malaria activity in vitro of volatile components of Lippia multiflora. Phytochem. 40: 1439-1442
31. Winter CA, Risley EA, Nuss GV (1962). Carrageenin induced oedema in hindpaw of rats as an assay for anti-inflammatory drugs. Proc Soc Exptl Biol Med 3:544-547